{"tool_name":"neoantimon","contents":["biotools","bioschemas"],"fetched_metadata":{"biotools":{"id":"neoantimon","home":"https://www.ncbi.nlm.nih.gov/pubmed/?term=33123738","summary":"A multifunctional R package for identification of tumor-specific neoantigens.\n\nIt is known that some mutant peptides, such as those resulting from missense mutations and frameshift insertions, can bind to the major histocompatibility complex and be presented to antitumor T cells on the surface of a tumor cell. These peptides are termed neoantigen, and it is important to understand this process for cancer immunotherapy. Here, we introduce an R package termed Neoantimon that can predict a list of potential neoantigens from a variety of mutations, which include not only somatic point mutations but insertions, deletions and structural variants","addition_date":"2021-01-18T11:33:50Z","last_update_date":"2021-03-08T13:23:58Z","tool_type":["Library"]},"bioschemas":{"name":"Neoantimon","home":"https://bio.tools/neoantimon","summary":"A multifunctional R package for identification of tumor-specific neoantigens.\n\nIt is known that some mutant peptides, such as those resulting from missense mutations and frameshift insertions, can bind to the major histocompatibility complex and be presented to antitumor T cells on the surface of a tumor cell. These peptides are termed neoantigen, and it is important to understand this process for cancer immunotherapy. Here, we introduce an R package termed Neoantimon that can predict a list of potential neoantigens from a variety of mutations, which include not only somatic point mutations but insertions, deletions and structural variants","tool_type":"sc:SoftwareApplication"}}}